Eton Pharmaceuticals (ETON) Debt to Equity: 2020-2025
Historic Debt to Equity for Eton Pharmaceuticals (ETON) over the last 4 years, with Sep 2025 value amounting to $1.31.
- Eton Pharmaceuticals' Debt to Equity rose 408.72% to $1.31 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.00, marking a year-over-year increase of 149.74%. This contributed to the annual value of $1.22 for FY2024, which is 251.07% up from last year.
- As of Q3 2025, Eton Pharmaceuticals' Debt to Equity stood at $1.31, which was up 4.26% from $1.26 recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Debt to Equity ranged from a high of $1.31 in Q3 2025 and a low of $0.02 during Q1 2021.
- For the 3-year period, Eton Pharmaceuticals' Debt to Equity averaged around $0.54, with its median value being $0.34 (2024).
- Per our database at Business Quant, Eton Pharmaceuticals' Debt to Equity declined by 23.90% in 2022 and then soared by 408.72% in 2025.
- Over the past 5 years, Eton Pharmaceuticals' Debt to Equity (Quarterly) stood at $0.08 in 2021, then decreased by 1.79% to $0.08 in 2022, then skyrocketed by 340.08% to $0.35 in 2023, then skyrocketed by 251.07% to $1.22 in 2024, then skyrocketed by 408.72% to $1.31 in 2025.
- Its Debt to Equity stands at $1.31 for Q3 2025, versus $1.26 for Q2 2025 and $1.22 for Q4 2024.